Osteoradionecrosis of the Midface and Mandible: Pathogenesis and Management

Abstract

Radiation therapy is an important and commonly used treatment modality for head and neck cancers. Osteoradionecrosis (ORN) is a potential debilitating complication of treatment, which most commonly affects the mandible. Management strategies are tailored to the severity of disease. Medical management including oral rinses, irrigations, antibiotics, and pharmacological treatments is viable for mild-to-moderate ORN. More severe disease is best addressed with a combination of medical management and surgical intervention aimed at aggressively removing devitalized tissue until bleeding bone is encountered and reconstructing the soft tissue and bone defect. Reconstruction with either regional vascularized flaps or vascularized osteocutaneous free flaps in case of larger full-thickness bone defects (greater than 6 cm) or anterior mandible (medial to mental foramen) is most appropriate. Maxillary ORN complications can present with a wide range of functional problems and facial disfigurement. Life-threatening and time-sensitive problems should be treated first, such as skull base bone coverage or correction of severe ectropion, to avoid blindness from exposure keratopathy. Then, less time-sensitive issues can be addressed next, such as nasal obstruction, velopharyngeal insufficiency, and chronic tearing. It may require a combination of specialists from different disciplines to address various issues that can arise from maxillary ORN.

Keywords

osteoradionecrosis - mandible reconstruction - midface reconstruction - maxillary reconstruction - fibula free flap - scapula free flap - nasal reconstruction - hyperbaric oxygen - PENTOCLO - pentoxifylline - tocopherol - clodronate

Publication History

Article published online:
24 December 2020

• References

• 1 Yeh SA. Radiotherapy for head and neck cancer. Semin Plast Surg 2010; 24 (02) 127-136
• 2 Maier A, Gaggl A, Klemen H. et al. Review of severe osteoradionecrosis treated by surgery alone or surgery with postoperative hyperbaric oxygenation. Br J Oral Maxillofac Surg 2000; 38 (03) 173-176
• 3 Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P. Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 2001; 23 (05) 389-398
• 4 Jacobson AS, Buchbinder D, Hu K, Urken ML. Paradigm shifts in the management of osteoradionecrosis of the mandible. Oral Oncol 2010; 46 (11) 795-801
• 5 Sroussi HY, Epstein JB, Bensadoun RJ. et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer Med 2017; 6 (12) 2918-2931
• 6 Teng MS, Futran ND. Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg 2005; 13 (04) 217-221
• 7 Nabil S, Samman N. Risk factors for osteoradionecrosis after head and neck radiation: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 113 (01) 54-69
• 8 Goyal S, Mohanti BK. Bilateral mandibular fracture related to osteoradionecrosis. Indian J Dent 2015; 6 (02) 107-109
• 9 Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Risk factors for and the role of dental extractions in osteoradionecrosis of the jaws: a national-based cohort study. Head Neck 2017; 39 (07) 1313-1321
• 10 Koga DH, Salvajoli JV, Alves FA. Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis 2008; 14 (01) 40-44
• 11 Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 1983; 41 (05) 283-288
• 12 Westermark A, Sindet-Pedersen S, Jensen J. Osteoradionecrosis, pathogenesis, treatment and prevention. Tandlaegebladet 1990; 94 (16) 669-673
• 13 Bras J, de Jonge HK, van Merkesteyn JP. Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol 1990; 11 (04) 244-250
• 14 Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg 1983; 41 (06) 351-357
• 15 Schwartz HC, Kagan AR. Osteoradionecrosis of the mandible: scientific basis for clinical staging. Am J Clin Oncol 2002; 25 (02) 168-171
• 16 Glanzmann C, Grätz KW. Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors. Radiother Oncol 1995; 36 (02) 94-100
• 17 Støre G, Boysen M. Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects. Clin Otolaryngol Allied Sci 2000; 25 (05) 378-384
• 18 Notani K, Yamazaki Y, Kitada H. et al. Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy. Head Neck 2003; 25 (03) 181-186
• 19 Jansma J, Vissink A, Bouma J, Vermey A, Panders AK, Gravenmade EJ. A survey of prevention and treatment regimens for oral sequelae resulting from head and neck radiotherapy used in Dutch radiotherapy institutes. Int J Radiat Oncol Biol Phys 1992; 24 (02) 359-367
• 20 Lubek JE, Hancock MK, Strome SE. What is the value of hyperbaric oxygen therapy in management of osteoradionecrosis of the head and neck?. Laryngoscope 2013; 123 (03) 555-556
• 21 Fritz GW, Gunsolley JC, Abubaker O, Laskin DM. Efficacy of pre- and postirradiation hyperbaric oxygen therapy in the prevention of postextraction osteoradionecrosis: a systematic review. J Oral Maxillofac Surg 2010; 68 (11) 2653-2660
• 22 Nabil S, Samman N. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int J Oral Maxillofac Surg 2011; 40 (03) 229-243
• 23 Rivero JA, Shamji O, Kolokythas A. Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, α-tocopherol, and clodronate. Oral Surg Oral Med Oral Pathol Oral Radiol 2017; 124 (05) 464-471
• 24 Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. Int J Radiat Oncol Biol Phys 2011; 80 (03) 832-839
• 25 Breik O, Tocaciu S, Briggs K, Tasfia Saief S, Richardson S. Is there a role for pentoxifylline and tocopherol in the management of advanced osteoradionecrosis of the jaws with pathological fractures? Case reports and review of the literature. Int J Oral Maxillofac Surg 2019; 48 (08) 1022-1027
• 26 Zhou Z, Lang M, Fan W. et al. Prevention of osteoradionecrosis of the jaws by low-intensity ultrasound in the dog model. Int J Oral Maxillofac Surg 2016; 45 (09) 1170-1176
• 27 Ribeiro GH, Minamisako MC, Rath IBDS. et al. Osteoradionecrosis of the jaws: case series treated with adjuvant low-level laser therapy and antimicrobial photodynamic therapy. J Appl Oral Sci 2018; 26: e20170172
• 28 Agrillo A, Filiaci F, Ramieri V. et al. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. Eur Rev Med Pharmacol Sci 2012; 16 (12) 1741-1747
• 29 Chen YT, Chang YC. Use of platelet-rich fibrin and surgical approach for combined treatment of osteoradionecrosis: a case report. J Int Med Res 2019; 47 (08) 3998-4003
• 30 Joshi A, Rajendraprasad JS, Shetty K. Reconstruction of intraoral defects using facial artery musculomucosal flap. Br J Plast Surg 2005; 58 (08) 1061-1066
• 31 Hatoko M, Kuwahara M, Tanaka A, Yurugi S. Use of facial artery musculomucosal flap for closure of soft tissue defects of the mandibular vestibule. Int J Oral Maxillofac Surg 2002; 31 (02) 210-211
• 32 Zhao YF, Zhang WF, Zhao JH. Reconstruction of intraoral defects after cancer surgery using cervical pedicle flaps. J Oral Maxillofac Surg 2001; 59 (10) 1142-1146
• 33 Tezel E. Buccal mucosal flaps: a review. Plast Reconstr Surg 2002; 109 (02) 735-741
• 34 Kim CM, Park MH, Yun SW, Kim JW. Treatment of pathologic fracture following postoperative radiation therapy: clinical study. Maxillofac Plast Reconstr Surg 2015; 37 (01) 31
• 35 Foster RD, Anthony JP, Sharma A, Pogrel MA. Vascularized bone flaps versus nonvascularized bone grafts for mandibular reconstruction: an outcome analysis of primary bony union and endosseous implant success. Head Neck 1999; 21 (01) 66-71
• 36 Santamaria E, Wei FC, Chen HC. Fibula osteoseptocutaneous flap for reconstruction of osteoradionecrosis of the mandible. Plast Reconstr Surg 1998; 101 (04) 921-929
• 37 Cordeiro PG, Santamaria E. A classification system and algorithm for reconstruction of maxillectomy and midfacial defects. Plast Reconstr Surg 2000; 105 (07) 2331-2346
• 38 Brown JS, Shaw RJ. Reconstruction of the maxilla and midface: introducing a new classification. Lancet Oncol 2010; 11 (10) 1001-1008
• 39 McCarthy CM, Cordeiro PG. Microvascular reconstruction of oncologic defects of the midface. Plast Reconstr Surg 2010; 126 (06) 1947-1959
• 40 Coskunfirat OK, Wei FC, Huang WC, Cheng MH, Yang WG, Chang YM. Microvascular free tissue transfer for treatment of osteoradionecrosis of the maxilla. Plast Reconstr Surg 2005; 115 (01) 54-60
• 41 Miles BA, Gilbert RW. Maxillary reconstruction with the scapular angle osteomyogenous free flap. Arch Otolaryngol Head Neck Surg 2011; 137 (11) 1130-1135
• 42 Futran ND, Wadsworth JT, Villaret D, Farwell DG. Midface reconstruction with the fibula free flap. Arch Otolaryngol Head Neck Surg 2002; 128 (02) 161-166